Welcome to the International Journal of Alcohol and Drug Research, an esteemed publication dedicated to advancing the understanding and research surrounding alcohol and drug-related issues. Published by Ohio State University, College of Social Work, this journal serves as a vital resource for professionals and scholars engaged in social sciences, public health, and epidemiological studies. Established as an Open Access journal since 2012, it ensures that valuable research findings are readily accessible to all, promoting awareness and disseminating knowledge critical in the fight against substance abuse. With a commendable impact in the field, the journal occupies a notable position in Scopus rankings, showcasing its contribution to social health, public health, and epidemiology. Covering an extensive scope with a commitment to rigorous research, the journal aims to foster collaboration between researchers, policymakers, and practitioners, ultimately driving innovative solutions and best practices in the realm of alcohol and drug research.

Advances in Dual Diagnosis, published by EMERALD GROUP PUBLISHING LTD, serves as a vital resource for professionals and researchers in the fields of psychiatry and mental health. With an ISSN of 1757-0972 and E-ISSN 2042-8324, this journal has been at the forefront of dual diagnosis research since its inception in 2008, aiming to bridge the gap in knowledge and practice regarding the co-occurrence of mental health disorders and substance use issues. Rated in the Q4 category for Psychiatry and Mental Health, it ranks 31st out of 45 in Nursing and Psychiatric Mental Health and 408th out of 567 in Medicine and Psychiatry, providing a unique platform for showcasing emerging research, innovative treatment strategies, and case studies that enhance understanding of complex patient needs. While the journal is not openly accessible, its contributions are crucial for driving forward the academic discourse and practical applications surrounding dual diagnosis. As we look to the future through 2024 and beyond, the Advances in Dual Diagnosis journal continues to strive for excellence in disseminating knowledge that benefits practitioners and scholars alike.

Welcome to the Journal of Addiction Medicine, a premier academic resource devoted to the field of addiction studies, published by LIPPINCOTT WILLIAMS & WILKINS. Since its inception in 2007, this esteemed journal has become a leader in disseminating groundbreaking research, with impressive rankings in the Q1 quartile across key disciplines such as Medicine (Miscellaneous), Pharmacology (Medical), and Psychiatry and Mental Health, reflecting its significance in the scholarly community. With an ISSN of 1932-0620 and an E-ISSN of 1935-3227, it caters to a diverse audience of researchers, clinicians, and students seeking to expand their understanding of addiction medicine. The journal's articles are primarily published in a non-open access format, ensuring high-quality research is accessible through institutional subscriptions. With a Scopus ranking that positions it within the top tiers of several relevant categories, the Journal of Addiction Medicine is essential for anyone committed to advancing knowledge in the field and addressing the complexities surrounding addiction.

Health Behavior and Policy Review is a leading journal in the domain of health policy and public health, published by PATIS Scholar Publishing Ltd. With an ISSN of 2326-4403, this interdisciplinary journal focuses on pertinent issues in health behavior, policy analysis, and the social determinants of health, making it an essential resource for researchers, professionals, and students alike. Although it operates in the open-access realm, it is strategically positioned within the Q3 quartile for Health Policy, Health (social science), and Public Health categories, reflecting its commitment to disseminating impactful research. Covering converged years from 2020 to 2024, the journal aims to bridge the gap between academic research and practical applications in health policy, contributing significantly to the field's advancements. With increasing visibility and relevance, Health Behavior and Policy Review serves as a pivotal platform for understanding and influencing health-related behavior across diverse populations, thereby enhancing public health outcomes.

Health & Justice, published by SPRINGERNATURE, is an esteemed open-access journal dedicated to the multifaceted intersection of health and legal studies, offering a critical platform for researchers and professionals alike. With an E-ISSN of 2194-7899, this journal has been fostering knowledge dissemination since its inception in 2013 and continues to be pivotal in advancing scholarly discourse in its fields. As of 2023, it proudly occupies a prestigious Q1 ranking in Law and a Q2 ranking in Public Health, Environmental and Occupational Health, reflecting its commitment to high-quality research and its relevance in contemporary debate. Residing in the United Kingdom, the journal covers a broad spectrum of topics related to health policy, legal frameworks pertaining to health care, and social justice issues, making it a vital resource for those aiming to influence practices and policies in these arenas. With an aim to provide accessible knowledge that bridges gaps between law and health disciplines, Health & Justice stands out as an essential source for researchers, students, and professionals navigating these interconnected fields.

JOURNAL OF PSYCHOACTIVE DRUGS, published by Routledge Journals, Taylor & Francis Ltd, stands as a leading resource in the fields of psychology and medicine, focusing on the intersection of psychoactive substances and their impact on human behavior. With an ISSN of 0279-1072 and E-ISSN 2159-9777, this esteemed journal has been a pivotal platform for rigorous research since its inception in 1967, contributing to the understanding of drug use, its societal implications, and therapeutic potentials. It currently holds a Q2 ranking in both the miscellaneous categories of Medicine and Psychology for 2023, reflecting its significant standing within academic circles. Moreover, its Scopus rankings place it at the 49th percentile in General Psychology and 101st in Medicine, underscoring its relevance in contemporary research. Although it is not available via Open Access, the journal maintains a commitment to advancing knowledge through its annual publications until 2024. JOURNAL OF PSYCHOACTIVE DRUGS is essential for researchers, professionals, and students seeking to explore the complexities of psychoactive substances and their effects in various contexts.

Suchttherapie, an esteemed journal published by GEORG THIEME VERLAG KG, serves as a critical platform within the fields of Applied Psychology and Psychiatry and Mental Health. Established in 2000 and continuing through 2024, this journal is committed to advancing the understanding and treatment of addiction and related psychological issues. Although it currently stands in the Q4 Quartile ranking and is categorized as low percentile in both Scopus Ranks and impact metrics, its significance lies in its dedication to disseminating cutting-edge research and clinical findings that contribute to the evolving landscape of therapeutic practices. Published in Germany, the journal facilitates unlimited access to the vital discourse surrounding mental health and addiction treatment, making it a valuable resource for researchers, professionals, and students alike seeking to enhance their knowledge and skills in this important area of study. As the field continues to grow, Suchttherapie plays a pivotal role in bridging practice with academic rigor, ensuring that readers remain informed on the latest methodologies and insights.

DRUGS-EDUCATION PREVENTION AND POLICY is a premier scholarly journal published by Taylor & Francis Ltd, focusing on the critical intersection of drug education, prevention strategies, and policy formulation. Established in 1994 and continuing through its converged years into 2024, this journal holds significant relevance within the health and social sciences fields, with commendable standings reflected in its 2023 category quartile rankings of Q2 in both Health (Social Science) and Medicine (Miscellaneous). With an impact ranking that places it in the 73rd and 67th percentiles respectively, it serves as an influential platform for researchers, professionals, and students to disseminate innovative research, case studies, and policy analyses. Those interested in the complexities of drug-related issues are encouraged to explore the insights provided by this journal, contributing to the ongoing discourse in effective prevention and education practices in the context of drug use and its social implications. Although access to articles is not open, the wealth of knowledge presented is invaluable for academia and policy formulation alike.

DRUG AND ALCOHOL REVIEW, published by Wiley, is a leading journal dedicated to advancing the scholarship in the fields of drug and alcohol research. Since its inception in 1989, this esteemed publication has provided a critical platform for the dissemination of innovative research findings, reviews, and theoretical papers, addressing pressing issues in substance use and addiction. With an impact factor that places it in the Q1 category in both Health (social science) and Medicine (miscellaneous), it ranks #78 out of 371 in the Scopus index for Health and #115 out of 398 in Medicine, reflecting its significant influence and high citation rates among scholars. The journal is committed to fostering a multidisciplinary approach, integrating perspectives from psychology, sociology, public health, and medicine, to inform policy and practice. Accessible to researchers and practitioners alike, *DRUG AND ALCOHOL REVIEW* serves as an essential resource for anyone invested in understanding and addressing the complexities of drug and alcohol use in society.

Nordic Studies on Alcohol and Drugs is a leading peer-reviewed journal published by SAGE PUBLICATIONS LTD, dedicated to advancing the understanding of alcohol and drug use from a Nordic perspective. Established in 1989 and operating as an Open Access journal since 2011, it provides a platform for researchers and professionals in the fields of health policy and social sciences, focusing on empirical research and interdisciplinary studies. With a commendable 2023 Impact Factor, ranking Q2 in both Health Policy and Health (Social Science), it has carved a significant niche in the scholarly community, fostering discussions around public health and drug-related issues. The journal covers diverse topics relevant to the Nordic context, making it a valuable resource for those seeking to understand patterns of alcohol and drug consumption and their implications. The journal reaches an international audience, underscoring its relevance across national borders, and aims to facilitate collaboration and knowledge sharing among scholars, practitioners, and policymakers.